Skip to main content
NIH funding notice RFA-MH-17-100

Novel Strategies for Targeting HIV-CNS Reservoirs without Reactivation (R21)

Closed on September 9, 2016.

Posted
April 6, 2016
Close date
September 9, 2016
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $444,750 in first-year total cost, median $222,375.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 AARR-Q (52)]2

Most frequent institutions

  1. UNIVERSITY OF NEBRASKA MEDICAL CENTER1
  2. UNIVERSITY OF NORTH TEXAS HLTH SCI CTR1
Competing awards under RFA-MH-17-100 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2017Targeting gut-brain axis to eliminate CNS reservoirs1R21MH113455-01BYRAREDDY, SIDDAPPA NUNIVERSITY OF NEBRASKA MEDICAL CENTER, NE$225,750ZRG1
2017Targeting latent HIV Astroglial Reservoirs without Reactivation1R21MH113452-01GHORPADE, ANUJAUNIVERSITY OF NORTH TEXAS HLTH SCI CTR, TX$219,000ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.